David Sans - Media
David Sans, FAARM, PhD, MBA is an finance and investment executive with a deep expertise healthcare, biotech and pharma. David is frequently interviewed as an expert in topics related to Mergers and Acquisitions, Fundraising (Public and Private Markets) and Investments in the Healthcare, Biotech and Pharma.
David Sans was interviewed by Carina Clingman and discussed intricacies of micro-IPOs, a funding strategy that can be particularly beneficial for certain biotech companies. David shared insights on what makes a successful IPO, the importance of investor support, and his vision for the future of financial services in biotech.
Whether you're a biotech founder considering funding options or simply interested in the intersection of finance and biotech, this episode offers valuable insights.
David Sans was interviewed by Dave Kittle to discuss what do healthcare leaders, including physical therapists, need to know about mergers, acquisitions, and home health innovations to navigate a rapidly changing industry.
Ever wonder what fuels innovation in biotech and healthcare finance? Join Jessica Koch as she interviews Dr. David Sans, FAARM, PhD, MBA—a powerhouse in healthcare finance and biotech strategy. As Director of Healthcare at EF Hutton, David has shaped major industry transactions, with a background at Pfizer, Novartis, and Mount Sinai Health. Don’t miss this insider’s look into the future of healthcare innovation!
David Sans was interviewed by Carina Clingman and discussed intricacies of micro-IPOs
David Sans was interviewed by Dave Kittle
Jessica Koch as she interviews Dr. David Sans, FAARM, PhD, MBA
Additional videos of David Sans.
David Sans discussed the role of CEOs of Biotech companies as it relates to raising funds for their business.
David Sans outlines how important it is to evolve finance towards an outcome-based investment model
David Sans highlights the keys to a successful IPO for Biotech companies